Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
New Data On Breast Imaging Using Cardiolite(R) To Be Presented At ASCO Breast Cancer Symposium
http://www.medicalnewstoday.com/articles/120647.php
Lantheus Medical Imaging, a worldwide leader in diagnostic imaging, announced that the company's leading imaging agent, Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection) will be featured in a new study on molecular breast imaging being presented on Sunday, September 7, 2008, at 7:00am -12:00pm (EDT) as part of the poster sessions (abstract #68) at the American Society of Clinical Oncology's 2008 Breast Cancer Symposium in Washington, DC.
Calculating How Breast Cancers Will Respond To Tamoxifen
http://www.medicalnewstoday.com/articles/120634.php
A discovery by Australian scientists could help clinicians decide which women with breast cancer will make good candidates for anti-oestrogen therapies, such as tamoxifen, and which will not.
Routine Use Of MRI Scans To Evaluate Breast Cancer Challenged By Study
http://www.medicalnewstoday.com/articles/120604.php
A new study suggests women with newly-diagnosed breast cancer who receive an MRI after their diagnosis face delays in starting treatment and are more likely to receive a mastectomy. The study, presented at the 2008 ASCO Breast Cancer Symposium, also shows that despite lack of evidence of their benefit, the routine use of MRI scans in women newly diagnosed increased significantly between 2004 and 2005, and again in 2006.
Early Phase Breast Cancer Study At GUMC Suggests New Approach Can Re-sensitize Tumors
http://www.medicalnewstoday.com/articles/120600.php
Women with hormone-receptor positive, metastatic breast cancer may take medications for years to help keep their cancer at bay, but when the tumor becomes resistant to anti-hormonal drugs, treatment with chemotherapy becomes the only option.
31st Annual San Antonio Breast Cancer Symposium
http://www.medicalnewstoday.com/articles/120550.php
<b>What:</b>The CTRC-AACR San Antonio Breast Cancer Symposium features the latest cutting-edge findings in laboratory, translational and clinical breast cancer research. This year's meeting focuses on new and promising therapeutic approaches, as well as strides being made in diagnosing and preventing breast cancer.
----------------------------------------------
** CANCER / ONCOLOGY News **
Positive SPA Reply From The FDA For TopoTarget's Pivotal Trial With Belinostat In PTCL
http://www.medicalnewstoday.com/articles/120656.php
TopoTarget A/S (OMX: TOPO) announced that a positive reply from the FDA was received on a Special Protocol Assessment (SPA) for a phase III trial for belinostat in PTCL (Peripheral T-Celle Lymphoma).
2-Day Ovarian Cancer Symposium Closes With A Promise To Find A Cure
http://www.medicalnewstoday.com/articles/120648.php
Cutting-edge discoveries in ovarian cancer research including developments on improving therapeutics for patients diagnosed with ovarian cancer and early detection of the disease were revealed as the 7th Biennial Ovarian Cancer Research Symposium came to a close Friday afternoon.
Calculating How Breast Cancers Will Respond To Tamoxifen
http://www.medicalnewstoday.com/articles/120634.php
A discovery by Australian scientists could help clinicians decide which women with breast cancer will make good candidates for anti-oestrogen therapies, such as tamoxifen, and which will not.
Children's Cancer Research Fund Launches CompleteTheCure.com
http://www.medicalnewstoday.com/articles/120623.php
Children's Cancer Research Fund® and partners Ronald McDonald Charities Upper Midwest, HopeKids Twin Cities and Gilda's Club announce the launch of <a href="http://www.CompleteTheCure.com" target="_blank" rel="nofollow">CompleteTheCure.
The Atomic Structure Of The Mammalian 'Fatty Acid Factory' Determined
http://www.medicalnewstoday.com/articles/120614.php
<b>Promising targets for drug development</b>Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders.
AVEO Initiates Phase 1b Combination Trial Of AV-951 With FOLFOX6 In Patients With Advanced Colorectal And Other Gastrointestinal Cancers
http://www.medicalnewstoday.com/articles/120505.php
AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that it has initiated another Phase 1b clinical study for its lead product candidate, the novel triple VEGF receptor inhibitor AV-951.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Shedding Light On Bowel Cancer
http://www.medicalnewstoday.com/articles/120638.php
An effective new method of diagnosing bowel (also known as colorectal, or large bowel) cancer using 'light' may soon be available, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.
----------------------------------------------
** LUNG CANCER News **
Lung Cancer Risk Models Created For Specific Populations, Prediction Refined
http://www.medicalnewstoday.com/articles/120606.php
Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Scottish Medicines Consortium (SMC) Gives Green Light To Effective Blood Cancer Drug Treatment Combination
http://www.medicalnewstoday.com/articles/120662.php
The Scottish Medicines Consortium (SMC) today announced a positive opinion for the anti-cancer drug rituximab to be combined with any chemotherapy combination as first-line treatment for follicular non-Hodgkin lymphoma (NHL),1 the 6th most common cancer in the UK.
Positive SPA Reply From The FDA For TopoTarget's Pivotal Trial With Belinostat In PTCL
http://www.medicalnewstoday.com/articles/120656.php
TopoTarget A/S (OMX: TOPO) announced that a positive reply from the FDA was received on a Special Protocol Assessment (SPA) for a phase III trial for belinostat in PTCL (Peripheral T-Celle Lymphoma).
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Painkillers Appear To Lower Prostate Cancer Marker
http://www.medicalnewstoday.com/articles/120715.php
New research from the US found that men who regularly took common painkillers like aspirin and ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs) had lower circulating levels of PSA (prostate-specific antigen), the biomarker that doctors use to assess whether a man is at risk of prostate cancer.
UNC Spin-Off Company Receives $2 Million Grant To Market Cancer Treatment Technology
http://www.medicalnewstoday.com/articles/120551.php
A University of North Carolina at Chapel Hill spin-off company has been awarded a $2 million grant to commercialize a new technology to improve radiation treatment of prostate cancer.The grant from the National Cancer Institute, as part of its Small Business Innovation Research program, will enable Morphormics Inc.
A Proclamation By The President Of The United States Of America: National Prostate Cancer Awareness Month, 2008
http://www.medicalnewstoday.com/articles/120499.php
National Prostate Cancer Awareness Month is an opportunity to underscore our commitment to fighting prostate cancer and to raise awareness about this highly treatable disease. Prostate cancer is the second most common type of cancer found in men, and one in six men will develop it during their lifetime.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment